Replies to post #705 on Venaxis Inc fka APPY

[pmony5]

Agreed APPY has always maintained trial & results by years end ... not sure where new earlier dates came from perhaps some of the new shorts lol... GLTA & make $$$$$$$$$$$

CEO stating in interview....

The study will enroll 2,000 evaluable patients in total and we expect to complete enrollment and report top-line data by the end of the year. We plan to submit our 510(k) package to the FDA as soon as possible

http://seekingalpha.com/article/1522902-exclusive-interview-with-stephen-lundy-venaxis-president-and-ceo?source=yahoo